Efficacy of avelumab + axitinib (A + Ax) versus sunitinib (S) by IMDC risk group in advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101 Meeting Abstract
| Authors: | Haanen, J. B. A. G.; Larkin, J.; Choueiri, T. K.; Albiges, L.; Rini, B. I.; Atkins, M. B.; Schmidinger, M.; Penkov, K.; Thomaidou, D.; Wang, J.; Mariani, M.; Di Pietro, A.; Motzer, R. J. |
| Abstract Title: | Efficacy of avelumab + axitinib (A + Ax) versus sunitinib (S) by IMDC risk group in advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101 |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120603009 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4574 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4574 -- Source: Wos |
